We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Australia-based Vaxine has received a grant of approximately $1 million from the Australian government for the commercialization of its new hepatitis B vaccine.
Jupiter Bioscience acquired a manufacturing facility from Aurobindo Pharma, Medak, Andhra Pradesh, as a part of its expansion plan for commercialization of specialty APIs, Chiral intermediates and key organic intermediates and bulk peptide raw materials.
Evotec AG has announced that the second milestone has been achieved in its four-year drug discovery collaboration with Takeda Pharmaceutical Company Limited.
After being pressured by Thai and international activists for years, GlaxoSmithKline has withdrawn its patent application for a key anti-retroviral drug in Thailand and India.
The World Health Organization gave its approval to Apo-triAvir, a generic HIV/AIDS medication made by the Toronto-based drug company Apotex, a "critical step" in allowing the drug to be exported to developing countries, the Toronto Star reports.